Sorafenib maintenance in FLT3-ITD mutated AML after allogeneic HCT: a real-world, single-center experience. - Diral E; Furnari G; Bruno A; Greco R; Clerici D; Marktel S; Farina F; Mastaglio S; Vago L; Piemontese S; Peccatori J; Corti C; et al. (Frontiers in oncology, 2024)